Skip to main content
Equibles
SHC logo

SHC

Sotera Health Co
$18.42 +0.03 (+0.16%) At close · Jul 10
Market Cap
$5.25B
Shares
285,166,994

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$18.42 Open$18.50 Day$18.20–18.55 52W$10.94–19.85 Avg vol 30d2.7M Short int16.0M · 5.6% float · 6.0d Short vol68% Last earningsMay 5, 2026 DataNov 2020–Jul 2026 Filing10-Q · May 5
Up next
Next earnings call
Aug 7, 2026 Est · unconfirmed · in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed May 5, 2026
AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Equibles Rating blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Buy Momentum Neutral Sentiment Neutral Fundamentals Strong Quant / Vol Moderate
      Market backdrop VIX 15 · calm Equity put/call 0.55
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +13%
      above
      Price vs 50-day avg +14%
      above
      RSI (14) 70
      overbought
      MACD trend Positive
      52-week position 84%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Neutral
      1-month return +13%
      trailing
      6-month return −5%
      trailing
      YTD return +4%
      this year
      Relative strength −14%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $16 › 200d $16 — 200d above 50d
      Institutional flow Distributing
      9 of 295 funds reported for Jun 30 · net -36.0K sh shares · +1 new
      Insider flow Distributing
      Net -$772.7M over 90 days · 100% sells
      Short interest Falling
      5.62% of float · ▼ -9.1% MoM · 6.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      295 holders — near 3-yr high, broad support
      Squeeze score 61
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth +6%
      Y/Y
      Gross margin 55%
      expanding
      EPS growth +69%
      Y/Y
      Free cash flow $149.2M
      Valuation P/E 44.9
      rich
      Balance sheet $1.8B
      net debt
      Quant / Vol
      risk profile
      Moderate
      Volatility 39%
      annualized · 1-yr
      Max drawdown −32%
      past year
      ATR 2.7%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record
      Latest guidance · from the Earnings Call filed Mar 31, 2026
      Total company revenue · 2026 Initiated $1.23B – $1.25B
      prior FY $1.16B midpoint +6.6% Y/Y
      Adjusted EBITDA · 2026 Non-GAAP Maintained $632M – $641M

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 3 · 3
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +13% Bullish
      Price vs 50-day avg
      +14% Bullish
      RSI (14)
      70 Bearish
      MACD trend
      Positive Bullish
      52-week position
      84% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Mixed
      Trend (MA cross) No cross
      50d $16 › 200d $16 — 200d above 50d
      Institutional flow Distributing
      9 of 295 funds reported for Jun 30 · net -36.0K sh shares · +1 new
      Insider flow Distributing
      Net -$772.7M over 90 days · 100% sells
      Short interest Falling
      5.62% of float · ▼ -9.1% MoM · 6.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      295 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      52-wk low $11 Now $18 · 84% 52-wk high $20
      vs 200-day avg +13% vs 50-day avg +14%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from its earnings releases, calls, and filings
      Metric Latest Period YoY
      net leverage ratio non-GAAP 3.2 Q1 2026 call —
      Adjusted EPS non-GAAP $0.86 full-year 2025 —

      Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

      Versus peers

      Diagnostics & Research — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      SHC
      Sotera Health Co
      this stock
      		$5.25B +4.4% +5.7% 44.9 5.6%
      TMO
      Thermo Fisher Scientific Inc.
      		 $195.86B -9.0% +0.4% 29.0 1.4%
      DHR
      Danaher Corp /De/
      		 $140.88B -12.7% +8.5% 38.4 1.5%
      IDXX
      Idexx Laboratories Inc /De
      		 $44.46B -16.7% +10.4% 41.5 2.5%
      NTRA
      Natera, Inc.
      		 $38.66B +17.8% -2.8% — 4.1%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      296
      % held
      92.9%
      Reported
      9 of 295
      Top holder
      Darsana Capital Partners…
      Held Float
      View
      Held by Funds
      Fund positions
      290
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      16.0M
      Days to cover
      6.0d
      Change
      -1.6M sh
      View
      Short Volume
      Short vol %
      68%
      As of
      Jul 10, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      18
      Value
      $270
      As of
      Jun 3, 2026
      View
      Off-Exchange
      Off-exchange %
      32.2%
      Week of
      Jun 15, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$772.7M
      Buyers / Sellers
      0 / 2
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $1.2B
      Net income (FY)
      $77.9M
      EPS diluted
      $0.27
      View
      Filings
      SEC Filings
      Latest
      Investor Event Transcript
      Filed
      Jun 30, 2026
      This year
      14
      View
      Proposed Sales
      Value
      $12.6M
      Shares
      750.0K
      Filed
      Dec 8, 2025
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jun 8, 2026
      View
      Investor Relations
      Latest news
      Sotera Health Announces Secondary…
      Published
      May 11, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      SHC +2.7% +13.2% -4.8% +3.8% +4.4%
      SPY +1.4% +4.1% +9.1% +1.1% +10.7%
      vs SPY +1.4% +9.1% -13.9% +2.7% -6.3%
      Key facts CIK 1822479 CUSIP 83601L102 13F (30d) 11 filings 11 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)